Results 121 to 130 of about 557 (132)

Cagrilintide-Semaglutide in Adults with Overweight or Obesity. Reply.

The New England journal of medicine
W Timothy, Garvey, Cynthia Karenina, Osorto Contreras, Melanie J, Davies   +2 more
openaire   +2 more sources

Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis

Journal of Diabetes & Metabolic Disorders
Hammad Rao, Sumet Kumar, Sheikh Muhammad Ebtehaj Ali, Harmain Muhammad Asif, Mukesh Kumar, Laksh Kumar, Adarsh Raja   +6 more
openaire   +1 more source

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3

EBioMedicine
Christelle Le Foll, Bernd Coester, Kirsten Raun   +2 more
exaly  

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants

Diabetes, Obesity and Metabolism
Anja Birk Kuhlman, Tine Baekdal, Astrid Eliasen   +2 more
exaly  

Review for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

  +5 more sources

Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Lancet, The
Francesco Giorgino, Julio Rosenstock, Klara R Klein   +2 more
exaly  

Author response for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

null Muhammad Ahmed, null Muhammad Hassan, null Muhammad Tahir, null Muhammad Hussain, null Faisal Islam, null Ghulam Taha Khan, null Muhammad Ahsan, null Shaheer Bin Shafiq, null Ahmed Ibrahim, null Ammad Uddin, null Saad Ahmed Waqas   +10 more
openaire   +1 more source

Cagrilintid - Ein Amylin-Analogon als Wirkverstärker von Inkretinmimetika

Österreichische Apothekerzeitung
openaire   +1 more source

Decision letter for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

openaire   +2 more sources

Cagrilintide enhances leptin sensitivity and energy expenditure in a sex-dependent manner in a polygenically predisposed rat model of obesity

openaire   +1 more source